Fulcrum Capital LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1724090 SEATTLE, WA

Position in VRTX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$7,926,817

+$560,694 QoQ

Shares Held

15,958

-3.3% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

1.92%

of 13F equity value

Holder Rank

#403

of 1,735 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fulcrum Capital LLC holds $7,926,817 across 1 Biotechnology name. VRTX ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	15,958	$7,926,817

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,926,817	15,958	-3.3%	Shares	Sole	2026-07-21
2026-03-31	$7,366,123	16,496	-0.7%	Shares	Sole	2026-04-30
2025-12-31	$7,533,029	16,616	+2.2%	Shares	Sole	2026-01-15
2025-09-30	$6,366,499	16,256	+2.9%	Shares	Sole	2025-10-28
2025-06-30	$7,033,269	15,798	+1.4%	Shares	Sole	2025-07-24
2025-03-31	$7,552,525	15,578	+0.5%	Shares	Sole	2025-04-08
2024-12-31	$6,239,433	15,494	+0.7%	Shares	Sole	2025-01-13
2024-09-30	$7,155,720	15,386	-0.1%	Shares	Sole	2024-10-22
2024-06-30	$7,216,413	15,396	+1.3%	Shares	Sole	2024-07-22
2024-03-31	$6,351,243	15,194	+0.8%	Shares	Sole	2024-04-17
2023-12-31	$6,132,239	15,071	-5.2%	Shares	Sole	2024-01-10
2023-09-30	$5,525,936	15,891	-0.4%	Shares	Sole	2023-10-13
2023-06-30	$5,613,316	15,951	-4.3%	Shares	Sole	2023-07-27
2023-03-31	$5,250,326	16,664	+22.3%	Shares	Sole	2023-05-11
2022-12-31	$3,936,360	13,631	+297.6%	Shares	Sole	2023-01-24
2022-09-30	$992,543	3,428	-8.2%	Shares	Sole	2022-10-17
2022-06-30	$1,051,922	3,733	—	Shares	Sole	2022-08-03
No filing history on record for this holder in this stock.